文献速递关节外科

医院衰弱风险评分预测初次全髋与全膝关节置换术后不良事件

Hospital Frailty Risk Score Predicts Adverse Events in Primary Total Hip and Knee Arthroplasty.
PubMed 文献 · J Arthroplasty · 2020-07-15

回顾性分析8250例2011至2019年间接受初次全髋或全膝关节置换术的患者,计算医院衰弱风险评分(HFRS)。中或高衰弱风险组再手术率10.6% vs 低风险组4.1%,再入院率9.6% vs 4.3%,多种并发症率及输血率均更高(P < .001)。多因素logistic回归显示高HFRS为再手术(OR = 2.1)、再入院(OR = 1.78)、内科并发症(OR = 3.72)、外科并发症(OR = 3.74)及其他并发症(OR = 9.00)的独立危险因素。HFRS可预测全髋与全膝关节置换术后不良事件。

要点

  • 中或高衰弱风险组再手术率10.6%、再入院率9.6%,均高于低风险组(P < .001)。
  • 高HFRS为再手术(OR = 2.1)、再入院(OR = 1.78)、内科并发症(OR = 3.72)、外科并发症(OR = 3.74)及其他并发症(OR = 9.00)的独立危险因素。
  • HFRS源自常规收集数据,医院无需额外努力或费用即可识别高危患者。

核心结论

  • HFRS可预测全髋与全膝关节置换术后不良事件。
  • HFRS源自常规收集数据,医院无需额外努力或费用即可识别高危患者。

研究设计与样本

  • 回顾性分析2011至2019年间接受全髋或全膝关节置换术的8250例患者,计算每例患者的HFRS。
  • 比较低衰弱风险与中或高衰弱风险患者间的再手术率、再入院率、并发症率及输血率,并采用多因素logistic回归评估HFRS与术后不良事件的关系。
  • 证据等级为III级-回顾性队列研究。

主要发现

  • 中或高衰弱风险组与低风险组比较:再手术率10.6% vs 4.1%(P < .001),再入院率9.6% vs 4.3%(P < .001)。
  • 中或高衰弱风险组与低风险组比较:外科并发症9.1% vs 1.8%(P < .001),内科并发症7.3% vs 1.1%(P < .001),其他并发症24.4% vs 2.0%(P < .001)。
  • 中或高衰弱风险组与低风险组比较:Clavien-Dindo IV级并发症4.1% vs 1.5%(P < .001),输血10.4% vs 1.3%(P < .001)。
  • 多因素logistic回归显示高HFRS为再手术(OR = 2.1;95%CI 1.46-3.09;P < .001)、再入院(OR = 1.78;95%CI 1.21-2.61;P = .003)的独立危险因素。
  • 多因素logistic回归显示高HFRS为内科并发症(OR = 3.72;95%CI 2.28-6.08;P < .001)、外科并发症(OR = 3.74;95%CI 2.41-5.82;P < .001)及其他并发症(OR = 9.00;95%CI 6.58-12.32;P < .001)的独立危险因素。

临床怎么用

  • 原文结论指出,HFRS源自常规收集数据,医院无需额外努力或费用即可识别高危患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Hospital Frailty Risk Score (HFRS) is a validated geriatric comorbidity measure derived from routinely collected administrative data. The purpose of this study is to evaluate the utility of the HFRS as a predictor for postoperative adverse events after primary total hip (THA) and knee (TKA) arthroplasty. METHODS: In a retrospective analysis of 8250 patients who had undergone THA or TKA between 2011 and 2019, the HFRS was calculated for each patient. Reoperation rates, readmission rates, complication rates, and transfusion rates were compared between patients with low and intermediate or high frailty risk. Multivariate logistic regression models were used to assess the relationship between the HFRS and postoperative adverse events. RESULTS: Patients with intermediate or high frailty risk showed a higher rate of reoperation (10.6% vs 4.1%, P < .001), readmission (9.6% vs 4.3%, P < .001), surgical complications (9.1% vs 1.8%, P < .001), internal complications (7.3% vs 1.1%, P < .001), other complications (24.4% vs 2.0%, P < .001), Clavien-Dindo grade IV complications (4.1% vs 1.5%, P < .001), and transfusion (10.4% vs 1.3%, P < .001). Multivariate logistic regression analyses revealed a high HFRS as independent risk factor for reoperation (odds ratio [OR] = 2.1; 95% confidence interval [CI], 1.46-3.09; P < .001), readmission (OR = 1.78; 95% CI, 1.21-2.61; P = .003), internal complications (OR = 3.72; 95% CI, 2.28-6.08; P < .001), surgical complications (OR = 3.74; 95% CI, 2.41-5.82; P < .001), and other complications (OR = 9.00; 95% CI, 6.58-12.32; P < .001). CONCLUSION: The HFRS predicts adverse events after THA and TKA. As it derives from routinely collected data, the HFRS enables hospitals to identify at-risk patients without extra effort or expense. LEVEL OF EVIDENCE: Level III-retrospective cohort study.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Meyer M, Parik L, Leiß F, et al. Hospital Frailty Risk Score Predicts Adverse Events in Primary Total Hip and Knee Arthroplasty. J Arthroplasty. 2020. PMID: 32800437. doi:10.1016/j.arth.2020.06.087

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。